Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections

NCT00870623 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00870623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections
Lead sponsor
University of Nebraska
Phase
Observational
Overall status
Completed
Start date
June 1, 2009
Completion date
January 13, 2016
Enrollment
223 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection